You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Medtronic
Baxter
McKesson
Harvard Business School

Last Updated: March 28, 2020

DrugPatentWatch Database Preview

FERRIC MALTOL - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for ferric maltol and what is the scope of freedom to operate?

Ferric maltol is the generic ingredient in one branded drug marketed by Shield Tx and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric maltol has forty-three patent family members in seventeen countries.

There are twenty drug master file entries for ferric maltol.

Summary for FERRIC MALTOL
International Patents:43
US Patents:3
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 20
Clinical Trials: 6
DailyMed Link:FERRIC MALTOL at DailyMed
Recent Clinical Trials for FERRIC MALTOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shields, Shields and AssociatesPhase 4
Hannover Medical SchoolPhase 4
Shield TherapeuticsPhase 1

See all FERRIC MALTOL clinical trials

US Patents and Regulatory Information for FERRIC MALTOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shield Tx ACCRUFER ferric maltol CAPSULE;ORAL 212320-001 Jul 25, 2019 RX Yes Yes   Start Trial   Start Trial   Start Trial
Shield Tx ACCRUFER ferric maltol CAPSULE;ORAL 212320-001 Jul 25, 2019 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Shield Tx ACCRUFER ferric maltol CAPSULE;ORAL 212320-001 Jul 25, 2019 RX Yes Yes   Start Trial   Start Trial   Start Trial
Shield Tx ACCRUFER ferric maltol CAPSULE;ORAL 212320-001 Jul 25, 2019 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Medtronic
Baxter
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.